METTL3 and posterior cortical atrophy: Treatment with BHB in LNCaP, PC3, and DU145 cells did not affect the expression levels of METTL3, indicating that the antagonistic effects of BHB on the malignant phenotype of PCa cells are not dependent on inhibition of the m6A modification pathway (Fig. 4I).